Author: Kwok, Benjamin; Brosnahan, Shari B.; Amoroso, Nancy E.; Goldenberg, Ronald M.; Heyman, Brooke; Horowitz, James M.; Jamin, Catherine; Sista, Akhilesh K.; Smith, Deane E.; Yuriditsky, Eugene; Maldonado, Thomas S.
Title: Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis Cord-id: kl63hglt Document date: 2020_9_10
ID: kl63hglt
Snippet: Coronavirus disease 2019 (COVID-19) is associated with increased rates of deep vein thrombosis (DVT) and pulmonary embolism (PE). Pulmonary Embolism Response Teams (PERT) have previously been associated with improved outcomes. We aimed to investigate whether PERT utilization, recommendations, and outcomes for patients diagnosed with acute PE changed during the COVID-19 pandemic. This is a retrospective cohort study of all adult patients with acute PE who received care at an academic hospital sys
Document: Coronavirus disease 2019 (COVID-19) is associated with increased rates of deep vein thrombosis (DVT) and pulmonary embolism (PE). Pulmonary Embolism Response Teams (PERT) have previously been associated with improved outcomes. We aimed to investigate whether PERT utilization, recommendations, and outcomes for patients diagnosed with acute PE changed during the COVID-19 pandemic. This is a retrospective cohort study of all adult patients with acute PE who received care at an academic hospital system in New York City between March 1st and April 30th, 2020. These patients were compared against historic controls between March 1st and April 30th, 2019. PE severity, PERT utilization, initial management, PERT recommendations, and outcomes were compared. There were more cases of PE during the pandemic (82 vs. 59), but less PERT activations (26.8% vs. 64.4%, p < 0.001) despite similar markers of PE severity. PERT recommendations were similar before and during the pandemic; anticoagulation was most recommended (89.5% vs. 86.4%, p = 0.70). During the pandemic, those with PERT activations were more likely to be female (63.6% vs. 31.7%, p = 0.01), have a history of DVT/PE (22.7% vs. 1.7%, p = 0.01), and to be SARS-CoV-2 PCR negative (68.2% vs. 38.3% p = 0.02). PERT activation during the pandemic is associated with decreased length of stay (7.7 ± 7.7 vs. 13.2 ± 12.7 days, p = 0.02). PERT utilization decreased during the COVID-19 pandemic and its activation was associated with different biases. PERT recommendations and outcomes were similar before and during the pandemic, and led to decreased length of stay during the pandemic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11239-020-02264-8) contains supplementary material, which is available to authorized users.
Search related documents:
Co phrase search for related documents- academic hospital and los stay length: 1, 2, 3
- academic hospital and lung disease: 1, 2, 3, 4
- additional evidence and lung disease: 1, 2
- admission prior and lmwh weight heparin: 1, 2
- admission prior and long term anticoagulation: 1
- admission prior and los stay length: 1, 2, 3, 4, 5
- admission prior and low molecular lmwh weight heparin: 1, 2
- admission prior and lung disease: 1, 2, 3, 4, 5, 6
- admission prior anticoagulation and long term anticoagulation: 1
- lmwh likely and low molecular lmwh weight heparin: 1
- lmwh weight heparin and los stay length: 1
- lmwh weight heparin and los stay length bleeding: 1
- lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- lmwh weight heparin and lung disease: 1
- long length and los stay length: 1, 2, 3, 4, 5
- los stay length and low molecular lmwh weight heparin: 1
- los stay length and lung disease: 1, 2, 3, 4
- los stay length bleeding and low molecular lmwh weight heparin: 1
Co phrase search for related documents, hyperlinks ordered by date